Trademark: 88205749
Status Date
Monday, June 27, 2022
Filing Date
Monday, November 26, 2018
Published for Opposition
Tuesday, March 26, 2019
Abandoned Date
Monday, June 27, 2022
5 Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder, pain, central nervous system disorders, and psychiatric diseases and disorders
Jun 27, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jun 27, 2022
Abandonment - No Use Statement Filed
Dec 1, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 30, 2021
Sou Extension 5 Granted
Nov 21, 2021
Sou Extension 5 Filed
Nov 30, 2021
Case Assigned To Intent To Use Paralegal
Nov 21, 2021
Sou Teas Extension Received
May 22, 2021
Notice Of Approval Of Extension Request E-Mailed
May 20, 2021
Sou Extension 4 Granted
May 20, 2021
Sou Extension 4 Filed
May 20, 2021
Sou Teas Extension Received
Nov 17, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 13, 2020
Sou Extension 3 Granted
Nov 13, 2020
Sou Extension 3 Filed
Nov 13, 2020
Sou Teas Extension Received
May 23, 2020
Notice Of Approval Of Extension Request E-Mailed
May 21, 2020
Sou Extension 2 Granted
May 21, 2020
Sou Extension 2 Filed
May 21, 2020
Sou Teas Extension Received
Nov 21, 2019
Notice Of Approval Of Extension Request E-Mailed
Nov 19, 2019
Sou Extension 1 Granted
Nov 19, 2019
Sou Extension 1 Filed
Nov 19, 2019
Sou Teas Extension Received
May 21, 2019
Noa E-Mailed - Sou Required From Applicant
Apr 30, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 30, 2019
Teas Change Of Owner Address Received
Mar 26, 2019
Official Gazette Publication Confirmation E-Mailed
Mar 26, 2019
Published For Opposition
Mar 6, 2019
Notification Of Notice Of Publication E-Mailed
Feb 12, 2019
Approved For Pub - Principal Register
Feb 7, 2019
Assigned To Examiner
Dec 14, 2018
New Application Office Supplied Data Entered
Nov 29, 2018
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
